Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. (DNTH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
dnth · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$145
Consensus
$112
+38.0% upside
Low
$55.00
Median: $120 · Last Close: $81.10
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$111.91
38.0% upside
High Target
$145
78.8%
Low Target
$55
-32.2%
Current Price
$81.10
as of today
Based on analyst price targets, the DNTH stock price prediction for the next 12 months ranges from $55 to $145. The consensus DNTH price forecast of $111.91 implies 38.0% upside from the current price of $81.10.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $78.68 | ↓ 2.99% |
1-day model range: $78.23–$79.13. Peak: $79.13 (-2.99%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $121 | +49.8% |
| 2028 | $158 | +94.5% |
| 2029 | $186 | +129.4% |
| 2030 | $206 | +154.1% |
| 2031 | — | +170.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DNTH · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-06 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-12 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-10 | Clear Street | Maintains | Buy→Buy |
| 2026-03-10 | Baird | Maintains | Outperform→Outperform |
| 2026-03-10 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-10 | Raymond James | Upgrade ↑ | Outperform→Strong Buy |
| 2026-03-09 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-03-09 | Truist Securities | Maintains | Buy→Buy |
| 2026-03-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Dianthus Therapeutics, Inc. (DNTH) stock. Of the recent 40 rating actions, 1 were upgrades and 0 were downgrades. 10 analysts currently cover DNTH.
Analyst Recommendation Trends
DNTH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 92.5% YoY
Revenue Next Year
$2M
↑ 41.3% YoY
EPS This Year
$-3.68
EPS Next Year
$-4.45
↑ 20.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast DNTH EPS of $-3.68 for the current fiscal year, based on estimates from 9 analysts. The DNTH revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DNTH stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DNTH price target is $111.91 (+38.0% upside), with an analyst consensus of Buy.
The DNTH short-term stock prediction for tomorrow is $78.68 (-2.99%). The DNTH stock price prediction for 2027 estimates an average of $121. The DNTH stock prediction for 2030 projects a range of $193–$219.
Dianthus Therapeutics, Inc. trades on NASDAQ under the ticker DNTH. The DNTH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
DNTH forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month DNTH price target is $111.91, with a high forecast of $145.00 and a low of $55.00. The median price target is shown in the chart above when available. This implies +38.0% potential upside from the current price of $81.10.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.